초록 ▼

A latch assembly for a computer or other electronic device includes a lever which is adapted to receive a spring arm integrally molded with a latch. The latch also includes integrally molded pivot pins which are guided by ramps into pivot holes in the lever to mate the latch and lever together. Once

A latch assembly for a computer or other electronic device includes a lever which is adapted to receive a spring arm integrally molded with a latch. The latch also includes integrally molded pivot pins which are guided by ramps into pivot holes in the lever to mate the latch and lever together. Once assembled, the latch is movable to and between engaged and disengaged positions for closure with a catch on the computer, electronic or other workpiece device. The latch assembly incorporates specific changes to existing parts while reducing the number of parts and the cost of and complexity for assembly. The design is much more easily accommodated in automated assembly equipment to further reduce assembly costs and increase productivity throughput.

대표청구항 ▼

A latch assembly for a computer or other electronic device includes a lever which is adapted to receive a spring arm integrally molded with a latch. The latch also includes integrally molded pivot pins which are guided by ramps into pivot holes in the lever to mate the latch and lever together. Once

A latch assembly for a computer or other electronic device includes a lever which is adapted to receive a spring arm integrally molded with a latch. The latch also includes integrally molded pivot pins which are guided by ramps into pivot holes in the lever to mate the latch and lever together. Once assembled, the latch is movable to and between engaged and disengaged positions for closure with a catch on the computer, electronic or other workpiece device. The latch assembly incorporates specific changes to existing parts while reducing the number of parts and the cost of and complexity for assembly. The design is much more easily accommodated in automated assembly equipment to further reduce assembly costs and increase productivity throughput. Chatlyyne et al., "A lipid emulsion with effective virucidal activity against H IV-1 and other common viruses." Foundation for Retrovirology and Human Health, 3rd Conference on Retroviruses and Opportunistic Infections, Washington D.C., U.S.A., 1996; Abstract #351. This reference is a book and is not being submitted at this time but if the Examiner requests the referenc it will be submitted. Dragon and Rennie "The ecology of anthrax spores: Tough but not invincible." Can. Vet. J. 1995; 36: 295-301. Drobniewski "Bacillus cereus and related species." Clin. MicrobioL Rev. 1993; 6: 324-338. Eriksson et al., "Virus validation of plasma-derived products produced by Pharmacia, with particular reference to immuno Globulins." Blood Coagulation and Fibtinolysis 1994; 5 (Suppl. 3): S37-S44. This reference is a book and is not being submitted at this time but if the Examiner requests the referenc it will be submitted. Florence "Non-ionic surfactant vesicles: preparation and characterization." In:. Gregoriadis G. ed. Liposome Technology. Liposome Preparations and Related Techniques. 2nd ed. vol. 1. CRC Press, 1993. This reference is a book and is not being submitted at this time but if the Examiner requests the referenc it will be submitted. Foster and Johnstone "Pulling the trigger: the mechanism of bacterial spore germination." MolecularMicrobiology 1990;4:137-141. Franz et al., "Clinical recognition and management of patients exposed to biological warfare agents." JAMA 1997; 278: 399-411. Fritz et al., "Pathology of experimental anthrax in'the rhesus monkey." Lab. Invest. 1995; 73: 691-702. Goodman & Gilman's "7he Pharmacological Basis of Therapeutics" Eds. Hardman et al., 9th Edition, Pubi. McGraw Hill, 1996; chapters 43 through 50. This reference is a book and is not being submitted at this time but if the Examiner requests the referenc it will be submitted. Graham et al., "Characteristics of a human cell line transformed by DNA from human adenovirus type 5." J Gen Virol 1977; 36: 59-74. Halvorson and Church, Bacteriol Rev 1957, 21:112. Hamouda et al., "Microbiocidal effects of liposome-like microemulsions on pathogenic Gram negative bacteria." In: American Society for Microbiology, 98th General Meeting, Atlanta, Georgia, U.S.A., 1998; Abstract A-52. Hamouda et al., "A novel surfactant nanoemulsion with broad-spectrum sporicidal activity against Bacillus species". Journal Infectious Disease 1999. 180:1939-1949. Hayden et al., "Plaque inhibition assay for drug susceptibility testing of influenza viruses." Antimicrob Agents Chemother. 1980 17: 865-870. Herlocher et al., "Sequence comparison of AIAA/6/60 influenza viruses: mutations, which may contribute to attenuation." Virus Res. 1996; 42:11-25. Hermonat et al., "The spermicide nonoxynol-9 does not inactivate papillomavirus." Sexually Trans Dis 1992; 19: 203-205. Hess et al., "Epidermal toxicity of disinfectants." Amer. J. Dent. 1991; 4: 51-56. Hills, J Gen Microbiol 4:38,1950. Horowitz et al., "Solvent/detergent-treated plasma: a vi rus-in activated substitute for fresh frozen plasma." Blood 1992; 79: 826-831. Huang et al., "Antiviral activity of some natural and synthetic sugar analogues." FEBS Letters. 1991; 291: 199-202. Ivins et al., "Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs." Vaccine 1995; 13: 1779-1784. Jackson et al., "PCR analysis of tissue samples from the 1979 Sverdlovsk anthrax victims: The presence of multiple Bacillus anthracis strains in 10 different victims." PNAS 1998; 95:1224-1229. Karalvanova and Spiro RG. "Sulphation of N-linked oligosacchaddes of vesicular stomatitis and influenza virus envelope glycoproteins: host cell specificity, subcellular localization adn identification of substituted saccharides." Bioch J 1998; 329: 511-518. Lamanna and Jones "Lethality for mice of vegetative and spore forms of Bacillus cereus and Bacillus cereus-like insect pathogens injected intraperitoneally and subcutaneously." J. Bact. 1963; 85: 532-535. Lamb and Krug "Orthomyxoviride: The viruses and their replication." In: Fields BN. Knipe DM. Howley PM. eds. Fields Virology, 3rd ed., Philadelphia Pennsylvania, U.S.A., Lippincoft-Raven Publishers, 1996; 1353-1395. Lee "Review: in vitro spermicidal tests." Contraception 1996; 54: 131-147. Lim and Chae"A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for beta-galactosidase." Biotechniques 1989; 7: 576-579. Lineaweaver et al., "Topical antimicrobial toxicity." Arch. Surg. 1985; 120: 267-270. Maha and Igarashi "The effect of nonionic detergent on dengue and Japanese encephalitis virus antigens in antigen detection ELISA and IgM-capture ELISA." Southeast Asian J Trop Med Pub Health 1997; 28: 718-722. This reference is a book and is not being submitted at this time but if the Examiner requests the referenc it will be submitted. Mammen et al., "Effective inhibitors of hemagglutination by influenza virus synthesized from polymers having active ester groups. Insight into mechanism of inhibition." J Med Chem 1995; 38: 4179-4190. Mendel et al., "Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection." Antimicrob Agents Chemother 1998; 42: 640-646. Meselson et al., "The Sverdlovsk anthrax outbreak of 1979." Science 1994; 266:1202-1208. Mobley "Biological warfare in the twentieth century: lessons from the past, challenges for the future." Military Med. 1995; 160: 547-553. Morgan "A brief review of formaldehyde carcinogenesis in relation to rat nasal pathology and human health risk assessment." ToxicoL PathoL 1997; 25: 291-307. Mosmann J. Immun. Methods 1983, 65, 55-63 Mulder and Hers "Influenza." Wolter-Noordhoff Publishing, 1972. O'Hagan "Recent advances in vaccine adjuvants for systemic and mucosal administration." J Pharmacy Pharmacol 1998; 50: 1-10. Pile et al., "Anthrax as a potential biological weapon." Arch. Intem. Med. 1998; 158: 429-434. Portocala et al., "Immunoelectrophoretic characterization of Sendai virus antigens." Virologie 1976; 27: 261-264. Russell "Bacterial spores and chemical sporicidal agents." Clin. Micro 1990; 3: 99-119. Schulze "Effects of glycolysation on the properties and functions of influenza virus hemagglutinin." J Infect Dis 1997; 176 (Suppl. 1): S24-28. Shibata "Germination of inactivated spores of Bacillus cereus T. Effect of preincubation with L-alanine or inosine on the subsequent germination." Japan. J. Microbiol. 1976; 20: 529-535. Smith et al., "Dihydropyrancarboxamides related to Zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis biological activity, and structure-activity relationships of 4-guanidino and 4-amino-4H-pyran-6-carboxamides." J Med Chem 1998; 41: 787-797. Titball and Manchee "Factors affecting the germination of spores of Bacillus anthracis." J. Appi. Bact. 1987; 62: 269-273. Waghorn and Goa, "Zanamivir." Drugs 1998; 55: 721-725. Welkos and Friedlanddr "Pathogenesis and genetic control of resistance to the Steme strain of Bacillus anthracis." Microb. Path. 1988; 4: 53-69. Welkos et al., "Differences in susceptibility of inbred mice to Bacillus anthracis" Infect. Immun. 1986; 51: 795-800. Yanagita, 1957, Arch Mikrobiol 26:329. Zeitlin et al., "Tests of vaginal microbicides in the mouse genital herpes model." Contraception 1997; 56: 329-335.